UNICEL® DXH 800 COULTER® CELLULAR ANALYSIS SYSTEM
Report
- Report Number
- 1061932-2012-02848
- Event Type
- Malfunction
- Date Received
- December 20, 2012
- Date of Event
- November 20, 2012
- Report Date
- November 21, 2012
- Manufacturer
- BECKMAN COULTER INC.
- Product Code
- GKZ
- PMA / PMN Number
- K081930
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) VISITED THE SITE AND EXAMINED THE SYSTEM. THE FSE FOUND THAT THE SYSTEM HAD POOR FLOW CELL PHASE ALIGNMENT. THE FSE REPLACED THE FLOWCELL, MAL SENSOR, AND SAMPLE LINE. THE FSE THEN PERFORMED A FLOW CELL PHASE ALIGNMENT WHICH RESOLVED THE ISSUE. SERVICE WAS VERIFIED FOLLOWING ESTABLISHED PROCEDURES AND THE INSTRUMENT CONFORMS TO PUBLISHED SPECIFICATIONS. THIS IS ONE OF TWO INDIVIDUAL MEDWATCH REPORTS BEING SUBMITTED AS TWO SEPARATE DEVICES WERE INVOLVED. REFERENCE MEDWATCH NUMBERS 1061932-2012-02847 AND 106-1932-2012-02848 FOR ALL ASSOCIATED REPORTS. THE SAME PATIENT SAMPLE IS INVOLVED IN EACH REPORT.
A CUSTOMER CONTACTED BECKMAN COULTER INC. (BEC) REPORTING THAT ERRONEOUS HIGH NE (NEUTROPHIL) AND LOW MO (MONOCYTE) RESULTS WERE GENERATED BY THE UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM WITHOUT INSTRUMENT GENERATED FLAGS. THIS SAME PATIENT SAMPLE WAS PREVIOUSLY TESTED ON ANOTHER SYSTEM AND YIELDED THE SAME INITIAL ERRONEOUS RESULT. THE SAMPLE WAS RETESTED AND YIELDED CORRECT RESULTS CONSISTENT WITH A RESULT FROM A PREVIOUS DAY'S INSTRUMENT RESULTS AND MANUAL SMEAR RESULTS FOR A SINGLE PATIENT. THERE WERE NO INJURIES OR CHANGES TO THE PATIENTS CARE OR TREATMENT. A BECKMAN COULTER FIELD SERVICE ENGINEER WAS DISPATCHED TO THE SITE TO EVALUATE THE SYSTEM.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | UNICEL® DXH 800 COULTER® CELLULAR ANALYSIS SYSTEM | COUNTER, DIFFERENTIAL CELL | GKZ | BECKMAN COULTER INC. | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR |